IRONWOOD PHARMACEUTICALS, INC. Other Nonoperating Income (Expense)
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Other Nonoperating Income (Expense) of $42.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $42.00K, a 7.69% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $42.00K, a 13.51% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $77.00K.
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $40.00K.
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2025 was $193.00K, a 69.84% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2024 was $640.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.00K 10-Q · filed 2026-08-06 | $84.00K 10-Q · filed 2026-08-06 | $161.00K derived: sum of 3 quarters · filed 2026-08-06 | $201.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $42.00K 10-Q · filed 2026-05-07 | $119.00K derived: sum of 2 quarters · filed 2026-05-07 | $159.00K derived: sum of 3 quarters · filed 2026-05-07 | $198.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $117.00K derived: sum of 2 quarters · filed 2026-02-26 | $156.00K derived: sum of 3 quarters · filed 2026-08-06 | $193.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $40.00K 10-Q · filed 2025-11-10 | $79.00K derived: sum of 2 quarters · filed 2026-08-06 | $116.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $39.00K 10-Q · filed 2026-08-06 | $76.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $37.00K 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $640.00K 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |